AFLURIA

Brand name authorized in: Austria Canada United States

Active ingredients

The drug AFLURIA contains a combination of these active pharmaceutical ingredients (APIs):

1 A/Guangdong-Maonan/SWL1536/2019 (H1N1)pdm09-like virus
UNII YTL6A60F5I - INFLUENZA A VIRUS A/VICTORIA/2454/2019 IVR-207 (H1N1) ANTIGEN (PROPIOLACTONE INACTIVATED)
Read about Influenza, inactivated, surface antigen
2 A/Hong Kong/2671/2019 (H3N2)-like virus
UNII OAT4H11ZT6 - INFLUENZA A VIRUS A/HONG KONG/2671/2019 IVR-208 (H3N2) ANTIGEN (PROPIOLACTONE INACTIVATED)
Read about Influenza, inactivated, surface antigen
3 B/Washington/02/2019-like virus
UNII KKA9J8NJL5 - INFLUENZA B VIRUS B/VICTORIA/705/2018 BVR-11 ANTIGEN (PROPIOLACTONE INACTIVATED)
Read about Influenza, inactivated, surface antigen
4 B/Phuket/3073/2013-like virus
UNII SYY92PMQJJ - INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B ANTIGEN (PROPIOLACTONE INACTIVATED)
Read about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Influenza, purified antigen
J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02473283, 02473313
US
FDA, National Drug Code
Identifier(s): 33332-220, 33332-320, 33332-420